Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis - Takeaways - MDSpire

Evaluating the Diagnostic Performance of Surveillance Methods for Hepatocellular Carcinoma in Cirrhotic Patients: A Systematic Review and Network Meta-Analysis

  • By

  • Gabriel Rogers

  • Efthymia Derezea

  • Libby Sadler

  • Hanyu Wang

  • Matthew E Cramp

  • Stephen D Ryder

  • Kelsey Watt

  • Penny Whiting

  • Morwenna Rogers

  • John Bell

  • Felicity Oppe

  • Ken Stein

  • Nicky J Welton

  • Hayley E Jones

  • July 17, 2026

Share

  • 1

    The study systematically reviews and synthesizes the diagnostic accuracy of 115 tests for hepatocellular carcinoma in cirrhotic patients.

  • 2

    Ultrasound and alpha-fetoprotein show similar low sensitivity for detecting very-early-stage hepatocellular carcinoma.

  • 3

    Contrast-enhanced MRI and CT demonstrate higher sensitivity across different tumor stages compared to ultrasound.

  • 4

    No genomic biomarkers significantly improve detection rates over conventional blood markers in this analysis.

  • 5

    Most studies included in the review are at high risk of bias, but findings remain robust when focusing on methodologically sound studies.

Original Source(s)

Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis

  • by Gabriel Rogers, Efthymia Derezea, Libby Sadler, Hanyu Wang, Matthew E Cramp, Stephen D Ryder, Kelsey Watt, Penny Whiting, Morwenna Rogers, John Bell, Felicity Oppe, Ken Stein, Nicky J Welton, Hayley E Jones

  • July 17, 2026

Related Content

Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management

Machine learning to develop and validate a model for predicting the risk of lymph node metastasis in colorectal cancer patients

From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors